欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号
FR/H/0419/006
药品名称
PERIOLIMEL N4E
活性成分
Glucose 0.0 00
剂型
Emulsion for infusion
上市许可持有人
BAXTER SAS 6 avenue Louis Pasteur 78310 Maurepas
参考成员国 - 产品名称
France (FR)
互认成员国 - 产品名称
Portugal (PT)
Slovakia (SK)
OLIMEL PERI N4E
Slovenia (SI)
Lithuania (LT)
OLIMEL PERI N4E infuzinė emulsija
Latvia (LV)
Malta (MT)
Norway (NO)
Poland (PL)
Olimel N9
Hungary (HU)
OLIMEL 9 g/l nitrogén emulziós infúzió
Finland (FI)
Estonia (EE)
Czechia (CZ)
PERIOLIMEL N4E
Cyprus (CY)
OLIMEL PERI N4E EMULSION FOR INFUSION
Bulgaria (BG)
Greece (GR)
OLIMEL
Austria (AT)
PeriOLIMEL 2,5 % mit Elektrolyten - Emulsion zur Infusion
Ireland (IE)
United Kingdom (Northern Ireland) (XI)
Iceland (IS)
Luxembourg (LU)
Netherlands (NL)
Belgium (BE)
Denmark (DK)
Germany (DE)
Olimel Peri 2,5% E Emulsion zur Infusion
Romania (RO)
OLIMEL N9E
Sweden (SE)
Italy (IT)
Spain (ES)
许可日期
2009/10/23
最近更新日期
2025/05/05
药物ATC编码
B05BA10 combinations
申请类型
TypeLevel1：
Known Active Substance
TypeLevel2：
Initial Application
TypeLevel3：
Full Dossier Art 8.3(i) Dir 2001/83/EC
TypeLevel4：
Chemical Substance
TypeLevel5：
Non Prescription (including OTC)
附件文件下载
Final Product Information
|
common_pl_cleanconsolidatedR1 with RMS additional recommended changes
Date of last change:2024/09/06
Final Product Information
|
common_spc_cleanconsolidatedR1 with RMS additional recommended changes
Date of last change:2024/09/06
Final PL
|
FR_H_0419_01_06_IA_040_d30_approval_20161019
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase